Price Reductions for 2014 Supplementary Cycle A
Summary of 1 August 2014 Price Reductions for 2014 Supplementary Cycle A by Drug / Manner of Administration / Percentage Reduction:
|
Drug |
MOA |
Percentage Reduction |
|---|---|---|
|
Riluzole |
Oral |
19.41% |
For further information about ex-manufacturer level weighted average disclosed prices for each brand, and confirmation of brands with no reductions, please see the legal determination on the Comlaw website.
Price reductions will apply to brands listed in Schedule 1 of the legal determination mentioned above. Those in Schedule 2 of the determination will not take a price disclosure reduction as their percentage difference was below 10%. Any brands listed after 31 January 2014 for a pharmaceutical item that has a determination in Schedule 1 will also take the reduction on 1 August 2014.
Final prices applicable on 1 August 2014 will be available under the ‘Confirmation of New Prices Resulting from EAPD Cycles’ link on this Web site from early July 2014.
An agreed process for responsible persons to raise any questions or concerns arising from an outcome mentioned above is set out in the Price Disclosure Dispute Resolution Administrative Process. The date for lodgement of disputes is 5 pm AEDT on Tuesday, 29 April 2014.
